Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum

精神分裂症谱系风险和保护因素的纵向神经影像和神经认知评估

基本信息

项目摘要

ABSTRACT The parent R01 project is a longitudinal study examining risk and protective factors in the schizophrenia (SZ) spectrum—from healthy controls (HCs) to individuals with schizotypal personality disorder (SPD) to recent-onset SZ patients (80 per group)—using MRI and neurocognitive approaches. It tests a neurobiological model which posits that individuals with SPD—an intermediate phenotype—have protective factors against developing threshold psychosis, such as preservation of frontal lobe and less severe temporal lobe abnormalities compared to SZ that lead to milder cognitive and social impairments. Examining natural language processing (NLP) as proposed in this supplement is in line with the scope and aims of the parent R01 project and may inform the key neurobiological model being tested. Moreover, examining NLP using novel measures of semantics and syntax in association with measures from the parent R01 of frontal and temporal white matter integrity/connectivity assessed with diffusion tensor imaging and cognitive domains such as processing speed and working memory is innovative. Speech and language provide a rich source of data on human thought, including semantic and emotional content, semantic coherence (i.e. flow of meaning), and syntactic structure and complexity (i.e. usage of parts of speech). There is a critical gap in our understanding of the linguistic mechanisms that underlie thought disorder in SZ spectrum. The use of automated linguistic analytic methods has been limited to only a few studies focused on discriminating SZ patients from HCs and predicting psychosis. Together with our colleagues with expertise in NLP at Icahn School of Medicine at Mount Sinai, we will use advanced computational speech analytic approaches to identify the linguistic basis of language production along a spectrum from normal to thought disordered. We will use optimal interviewing techniques1 to obtain open-ended 30-45 minute narratives from the large (N = 240) English-speaking sample in the parent R01 study, with a range of language disturbances across the spectrum ranging from none/subtle to severe. NLP techniques including Latent Semantic Analysis2 (LSA) and part-of-speech (POS) tagging3,4 will be conducted using artificial intelligence to examine semantic and syntactic language features to include in our overall neurobiological model. These analyses yield fine-grained indices of speech and language that may more accurately capture thought disorder. Three specific aims will assess (1) semantic coherence in language production using LSA2 and examine its association with positive symptoms and functional impairment across the spectrum; (2) syntactic complexity in language production using POS tagging3,4 and measure acoustic features to examine their association with negative symptoms and functional impairment; and (3) the relationship between language and speech features (semantic, syntactic, and acoustic) with putative white matter integrity assessed using diffusion tensor imaging.
抽象的 父项目 R01 是一项纵向研究,检查精神分裂症的风险和保护因素 (SZ)谱——从健康对照(HC)到精神分裂型人格障碍(SPD)个体 最近发病的精神分裂症患者(每组 80 名)——使用 MRI 和神经认知方法。 该模型假设患有 SPD(一种中间表型)的个体具有针对 发展精神病阈值,例如保留额叶和不太严重的颞叶 与 SZ 相比,这些异常会导致较轻的认知和社交障碍。 本补充中提出的语言处理(NLP)符合家长的范围和目标 R01 项目可能会为正在测试的关键神经生物学模型提供信息,此外,还可以使用新颖的方法来检查 NLP。 与来自额叶和颞叶的父 R01 的测量相关的语义和句法测量 通过扩散张量成像和认知领域评估白质完整性/连接性,例如 处理速度和工作记忆是创新的。 语音和语言提供了有关人类思维的丰富数据源,包括语义和情感 内容、语义连贯性(即意义的流动)以及句法结构和复杂性(即部分的使用) 我们对思想背后的语言机制的理解存在着严重的差距。 自动语言分析方法的使用仅限于少数。 研究重点是区分 SZ 患者与 HC 并预测精神病。 与我们在西奈山伊坎医学院拥有 NLP 专业知识的同事一起,我们将使用 先进的计算语音分析方法来识别语言产生的语言基础 我们将使用最佳访谈技巧1来获得从正常到思维混乱的范围。 来自父 R01 中大型(N = 240)英语样本的 30-45 分钟开放式叙述 研究中存在一系列从无/微妙到严重的语言障碍。 将使用包括潜在语义分析2(LSA)和词性(POS)标记3,4在内的技术 使用人工智能来检查语义和句法语言特征,以包含在我们的整体中 这些分析产生了更细粒度的言语和语言指数。 准确捕捉思维混乱。 三个具体目标将评估 (1) 使用 LSA2 的语言生成中的语义连贯性并检查其 (2) 句法复杂性 使用词性标记 3,4 进行语言生成,并测量声学特征以检查其与 阴性症状和功能障碍;以及(3)语言和言语特征之间的关系。 (语义、句法和声学),并使用扩散张量成像评估假定的白质完整性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIN A. HAZLETT其他文献

ERIN A. HAZLETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIN A. HAZLETT', 18)}}的其他基金

CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
  • 批准号:
    10701136
  • 财政年份:
    2023
  • 资助金额:
    $ 20.68万
  • 项目类别:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
针对自杀高风险退伍军人的决策失误和抑郁症的新型认知补救干预措施:COVID-19 大流行期间的安全远程医疗方法
  • 批准号:
    10366431
  • 财政年份:
    2022
  • 资助金额:
    $ 20.68万
  • 项目类别:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
针对自杀高风险退伍军人的决策失误和抑郁症的新型认知补救干预措施:COVID-19 大流行期间的安全远程医疗方法
  • 批准号:
    10539275
  • 财政年份:
    2022
  • 资助金额:
    $ 20.68万
  • 项目类别:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
精神分裂症谱系风险和保护因素的纵向神经影像和神经认知评估
  • 批准号:
    10542376
  • 财政年份:
    2020
  • 资助金额:
    $ 20.68万
  • 项目类别:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
精神分裂症谱系风险和保护因素的纵向神经影像和神经认知评估
  • 批准号:
    10319171
  • 财政年份:
    2020
  • 资助金额:
    $ 20.68万
  • 项目类别:
CSR&D Research Career Scientist Award Application
企业社会责任
  • 批准号:
    10177966
  • 财政年份:
    2018
  • 资助金额:
    $ 20.68万
  • 项目类别:
CSR&D Research Career Scientist Award Application
企业社会责任
  • 批准号:
    10426091
  • 财政年份:
    2018
  • 资助金额:
    $ 20.68万
  • 项目类别:
CSR&D Research Career Scientist Award Application
企业社会责任
  • 批准号:
    9892965
  • 财政年份:
    2018
  • 资助金额:
    $ 20.68万
  • 项目类别:
CSR&D Research Career Scientist Award Application
企业社会责任
  • 批准号:
    9551820
  • 财政年份:
    2018
  • 资助金额:
    $ 20.68万
  • 项目类别:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
低自杀风险和高自杀风险退伍军人情感不稳定的神经生物学
  • 批准号:
    10311973
  • 财政年份:
    2017
  • 资助金额:
    $ 20.68万
  • 项目类别:

相似国自然基金

老年期痴呆患者基础性日常生活活动能力损害的认知神经心理学基础及测量优化
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
基于VR技术的养老机构老年人ADL康复训练和评估量化体系构建及应用研究
  • 批准号:
    81902295
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 20.68万
  • 项目类别:
Extending Digital Survivorship Needs Assessment Planning Tools to Enhance Communication in the Head and Neck Cancer Survivor-Caregiver-Provider Triad
扩展数字化生存者需求评估规划工具,以加强头颈癌生存者-护理者-提供者三人组中的沟通
  • 批准号:
    10831265
  • 财政年份:
    2022
  • 资助金额:
    $ 20.68万
  • 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
  • 批准号:
    10406064
  • 财政年份:
    2021
  • 资助金额:
    $ 20.68万
  • 项目类别:
Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities
推进熟练护理机构中老年人的康复模式
  • 批准号:
    10768215
  • 财政年份:
    2021
  • 资助金额:
    $ 20.68万
  • 项目类别:
Statewide Implementation of CAPABLE-Community Aging in Place, Advancing Better Living for Elders in the Michigan Medicaid Home and Community Based Waiver Program
在全州范围内实施能力社区老龄化,促进密歇根州医疗补助家庭和社区豁免计划中老年人的更好生活
  • 批准号:
    10117746
  • 财政年份:
    2020
  • 资助金额:
    $ 20.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了